Navigation Links
New Study Results Published in the New England Journal of Medicine Show Dabigatran Etexilate Mesylate Reduces the Risk of Recurrent Venous Thromboembolism
Date:2/20/2013

ative risk reduction 46 percent; p<0.001)
  • Trend toward lower risk of major bleeding alone: 13 patients, 0.9 percent versus 25 patients,1.8 percent (relative risk reduction 48 percent; p=0.06)
  • A higher rate of acute coronary syndrome (ACS) events was observed in the dabigatran group versus warfarin (13 patients, 0.9 percent versus three patients, 0.2 percent, respectively; p=0.02)
  • RE-SONATE

    • Design: 1,343 patients randomized to dabigatran 150 mg (681 patients) or placebo (662 patients) for six months with extended follow-up to evaluate the long-term risk of recurrence (12 months after completion of study treatment)
    • Efficacy: 92 percent risk reduction for recurrent or fatal VTE with dabigatran versus placebo (three patients, 0.4 percent versus 37 patients, 5.6 percent; p<0.001 for superiority)
    • Safety: the incidence of major bleeding was two patients in the dabigatran group versus zero patients in the placebo group. A higher rate of major or clinically relevant bleeding in the dabigatran group versus no treatment was observed (36 patients, 5.3 percent versus 12 patients, 1.8 percent; p=0.001)

    * Pradaxa® (dabigatran etexilate mesylate) capsules are not approved by the U.S. Food and Drug Administration for the prevention of recurrent VTE or the treatment of acute VTE.

    About Pradaxa® (dabigatran etexilate mesylate) Capsules

    Indications and Usage
    Pradaxa® (dabigatran etexilate mesylate) capsules is indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation.

    IMPORTANT SAFETY INFORMATION ABOUT PRADAXA

    CONTRAINDICATIONS
    PRADAXA is contraindicated in patients with:

    • Active pathological bleeding
    • A known serious hypersensitivity rea
      '/>"/>

    SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
    2. Study Showed Patients Treated With The miraDry© System Experienced 82 Percent Sweat Reduction On Average
    3. Asubio Initiates Landmark Clinical Study in Spinal Cord Injury
    4. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
    5. Shingles Vaccine is Safe, According to New Study
    6. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
    7. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
    8. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
    9. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
    10. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
    11. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/4/2015)... -- IGI Laboratories, Inc. (NYSE MKT: IG), a ... today announced it has submitted its seventh abbreviated new ... Administration (FDA) of 2015, which brings the Company,s total ... to twenty-nine. Jason Grenfell-Gardner , President ... current pipeline of twenty-nine submissions, exclusive of our four ...
    (Date:9/4/2015)... 04, 2015 ... announced the addition of the "Investigation ... report to their offering. ... repeating disaccharide units of Na-glucuronate-N-acetylglucosamine. As a ... matrix, sodium hyaluronate can lubricate the joint, ...
    (Date:9/3/2015)... 2015 Report Details What can ... are going to grow at the fastest rates? Visiongain,s ... assessing data, trends, opportunities and prospects there. ... Discover the most lucrative areas in the industry and ... assess forecasted sales at overall world market and regional ...
    Breaking Medicine Technology:IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Investigation Report on China's Sodium Hyaluronate Market 2015 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025: Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4
    (Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, a ... charity effort to provide for the family of Grace, a young local girl ... cardiomyopathy often leads to diastolic dysfunction – the inability to adequately move blood ...
    (Date:9/4/2015)... ... September 04, 2015 , ... ... Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary Supplements and ... rules constantly evolving in the consumer goods industry, it can be difficult for ...
    (Date:9/4/2015)... ... September 04, 2015 , ... Scalability Experts ... the Year” awards at this year’s Microsoft Worldwide Partner Conference that was held ... the Year” Award Winner for Data Platform services, the 2015 HP and Microsoft ...
    (Date:9/4/2015)... Francisco, CA (PRWEB) , ... September 04, 2015 ... ... Amini, announces that CEREC technology is now available at CitiDent. CEREC is a ... machinery. In addition to saving time for patients by eliminating the need for ...
    (Date:9/4/2015)... ... 04, 2015 , ... Mike Day, a former Navy SEAL who was shot ... World Championships in Kona on October 10th. , Mike is running the race to ... combat and the cutting-edge treatments that restore their quality of life. More ...
    Breaking Medicine News(10 mins):Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Navy SEAL Shot 27 Times Competes in Ironman World Championship in Kona to Raise Money for Veteran's Suffering from TBI and PTSD 2
    ... HealthDay Reporter , MONDAY, Sept. 27 (HealthDay News) ... the metal mesh tubes used to keep clogged arteries ... came out on top, South Korean researchers report. ... the study found. Coating stents with time-released drugs ...
    ... Clinic researchers and their international colleagues have discovered genetic ... of women when taking aromatase inhibitors to treat their ... that many women halt their lifesaving medication. The findings ... of Clinical Oncology . "Many women stop taking ...
    ... and close friends are more sensitive to early signs ... researchers at Washington University School of Medicine in St. ... having memory problems by testing them with a variety ... words or comparing shapes of objects. Washington University researchers ...
    ... 2010) Virginia Commonwealth University School of Medicine and ... impotence drug Viagra, in combination with doxorubicin, a powerful ... while alleviating the damage to the heart at the ... decades the chemotherapeutic agent doxorubicin has been used to ...
    ... - The National Cancer Institute has awarded a five-year, ... at Chapel Hill,s Carolina Center of Cancer Nanotechnology Excellence ... for research to improve the diagnosis and treatment of ... support the continued work of the center launched in ...
    ... continuing in Afghanistan, UCLA has helped develop a first-of-its-kind ... in critical combat casualty care. The program will not ... but civilian care as well. Based ... Operation Iraqi Freedom and Operation Enduring Freedom in Afghanistan, ...
    Cached Medicine News:Health News:In Test of Stents, Old Standby Wins Out 2Health News:Mayo collaboration finds source of breast drug side effect 2Health News:Friends, family detect early Alzheimer's signs better than traditional tests 2Health News:Friends, family detect early Alzheimer's signs better than traditional tests 3Health News:VCU study: Researchers discover a drug combination that shrinks tumors in vivo 2Health News:NCI awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence 2Health News:NCI awards $13.6 million to UNC's Carolina Center of Cancer Nanotechnology Excellence 3Health News:UCLA develops combat casualty care educational program for US armed forces 2Health News:UCLA develops combat casualty care educational program for US armed forces 3
    ... The Polaris system delivers the ... cost effective and easy to use, ... level of precision measurement with unprecedented ... both active and passive tools, the ...
    Penfield Dissector #4...
    Leroy scalp clips, sterile, disposable, plastic, infant size, ten clips/package....
    Disposable scalp clip applier, comes loaded with 12 Leroy-Raney clips, ergonomic, easy to handle and position the clip....
    Medicine Products: